The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Subclinical Atrial Fibrillation and the Risk of Stroke
Open accessAbstract
BACKGROUND: One quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented atrial fibrillation. We evaluated whether subclinical episodes of rapid atrial rate detected by implanted devices were associated with an increased risk of ischemic stroke in patients who did not have other evidence of atrial fibrillation. METHODS: We enrolled 2580 patients, 65 years of age or older, with hypertension and no history of atrial fibrillation, in whom a pacemaker or defibrillator had recently been implanted. We monitored the patients for 3 months to detect subclinical atrial tachyarrhythmias (episodes of atrial rate >190 beats per minute for more than 6 minutes) and followed them for a mean of 2.5 years for the primary outcome of ischemic stroke or systemic embolism. Patients with pacemakers were randomly assigned to receive or not to receive continuous atrial overdrive pacing. RESULTS: By 3 months, subclinical atrial tachyarrhythmias detected by implanted devices had occurred in 261 patients (10.1%). Subclinical atrial tachyarrhythmias were associated with an increased risk of clinical atrial fibrillation (hazard ratio, 5.56; 95% confidence interval [CI], 3.78 to 8.17; P<0.001) and of ischemic stroke or systemic embolism (hazard ratio, 2.49; 95% CI, 1.28 to 4.85; P=0.007). Of 51 patients who had a primary outcome event, 11 had had subclinical atrial tachyarrhythmias detected by 3 months, and none had had clinical atrial fibrillation by 3 months. The population attributable risk of stroke or systemic embolism associated with subclinical atrial tachyarrhythmias was 13%. Subclinical atrial tachyarrhythmias remained predictive of the primary outcome after adjustment for predictors of stroke (hazard ratio, 2.50; 95% CI, 1.28 to 4.89; P=0.008). Continuous atrial overdrive pacing did not prevent atrial fibrillation. CONCLUSIONS: Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism. (Funded by St. Jude Medical; ASSERT ClinicalTrials.gov number, NCT00256152.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrieved data provide an insight into the natural history and associated sequelae (Healey 2012, Kaplan 2019, Van Gelder 2017, Varma 2005).63,69,74,75”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“Device-detected, subclinical, atrial, high-rate episodes lasting 6 minutes to 24 hours are associated with increased stroke risk, but the absolute risk is considerably lower than expected based on risk factors alone (Glotzer 2003, Healey 2012, van Gelder 2017).74,75,79”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Depending on the risk profile of the population studied, such AHRE are detected in 10-15% of pacemaker patients.141”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Traditional 24-h monitoring devices (i.e., Holter monitors) often do not detect symptomatic or clinically meaningful arrhythmias [6, 7].”
From Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring (2016) · cites this paper as [6]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750
von Minckwitz, G., du Bois, A., Schmidt, M., Maass, N., Čufer, T., de Jongh, F. E., Maartense, E., Zielinski, C. C., Kaufmann, M., Bauer, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6618 · Cited by 674
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1001/archinte.147.9.1561 · DOI · Paper page
Cited by
Sorted by citations
Items 601–700 of 1,001
Tomita, H., Sasaki, S., Hagii, J., & Metoki, N. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.03.002 · Cited by 28
Thromboembolism in the Absence of Atrial Fibrillation
Smietana, J. J., Plitt, A., & Halperin, J. L. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.04.027 · Cited by 26
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK
Rinciog, C., Sawyer, L., Diamantopoulos, A., Elkind, M. S. V., Reynolds, M. R., Tsintzos, S., Ziegler, P., Quiroz, M. E., Wolff, C., & Witte, K. K. (2019) · Open Heart · doi:10.1136/openhrt-2019-001037 · Cited by 27
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Campo, D., Élie, V., de Gallard, T., Bartet, P., Morichau-Beauchant, T., Genain, N., Fayol, A., Fouassier, D., Pasteur‐Rousseau, A., Puymirat, É., et al. (2022) · JMIR Formative Research · doi:10.2196/37280 · Cited by 26
“Atrial fibrillation is associated with a 5-fold increase in the risk of stroke [5-9].”
BackgroundBhat, A., Chen, H. H. L., Khanna, S., Mahajan, V., Gupta, A. A., Burdusel, C., Wolfe, N., Lee, L., Gan, G. C. H., Dobbins, T., et al. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.05.018 · Cited by 25
Hiraoka, D., Inui, T., Kawakami, E., Oya, M., Tsuji, A., Honma, K., Kawasaki, Y., Ozawa, Y., Shiko, Y., Ueda, H., et al. (2022) · JMIR Formative Research · doi:10.2196/35396 · Cited by 30
“However, approximately one-third of patients with paroxysmal AF are asymptomatic, making it difficult to diagnose an arrhythmia without symptoms unless an ECG monitoring is performed in a medical facility [1,3-5].”
BackgroundKalarus, Z. F., Średniawa, B., Mitręga, K. A., Wierucki, Ł., Sokal, A., Lip, G. Y. H., Bandosz, P., Stokwiszewski, J., Boidol, J., Zieleniewicz, P., et al. (2023) · Kardiologia Polska · doi:10.33963/kp.a2022.0202 · Cited by 27
“More detailed studies are available for selected subgroups such as post-stroke patients [5], subjects with implanted pacemakers or implantable cardioverter defibrillators [6], voluntary screening program participants [7], smartwatch users [8, 9], and local communities.”
Guénancia, C., Pujos, C., Debomy, F., Malapert, G., Laurent, G., & Bouchot, O. (2015) · BioMed Research International · doi:10.1155/2015/703685 · Cited by 27
Silent Atrial Fibrillation as a Stroke Risk Factor and Anticoagulation Indication
Glotzer, T. V., & Ziegler, P. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.023 · Cited by 27
Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up
Stamboul, K., Zeller, M., Fauchier, L., Gudjoncik, A., Buffet, P., Garnier, F., Guenancia, C., Lorgis, L., Beer, J., Touzery, C., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307253 · Cited by 26
Anticoagulation in Heart Failure: a Review.
Zeitler, E. P., & Eapen, Z. J. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1250 · Cited by 28
Risk Factors and Prognosis for Clot Formation on Cardiac Device Leads
Rahbar, A. S., Azadani, P. N., THATIPELLI, S., Fleischmann, K. E., NGUYEN, N., & Lee, B. K. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12210 · Cited by 27
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024
Fernandes, F., Simões, M. V., Correia, E. D. B., Marcondes‐Braga, F. G., Coelho‐Filho, O. R., Mesquita, C. T., Mathias, W., Antunes, M. D. O., Arteaga-Fernández, E., Rochitte, C. E., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240415i · Cited by 26
McIntyre, W. F., Benz, A. P., Healey, J. S., Connolly, S. J., Yang, M., Lee, S. F., Field, T. S., Alings, M., Benezet‐Mazuecos, J., Boriani, G., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.069903 · Cited by 26
Niiranen, T., Schnabel, R. B., Schutte, A. E., Biton, Y., Boriani, G., Buckley, C. M., Cameron, A. C., Damasceno, A. A. M., Diederichsen, S. Z., Doehner, W., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.071047 · Cited by 29
Management of postoperative atrial fibrillation after cardiac surgery
Ha, A. C. T., Mazer, C. D., Verma, S., Yanagawa, B., & Verma, A. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000264 · Cited by 26
Quinn, F. R., Gladstone, D. J., Ivers, N. M., Sandhu, R. K., Dolovich, L. R., Ling, A. L. H., Nakamya, J., Ramasundarahettige, C. F., Frydrych, P. A., Henein, S., et al. (2018) · CMAJ Open · doi:10.9778/cmajo.20180001 · Cited by 26
Impact of atrial high-rate episodes on the risk of future stroke
Nakano, M., Kondo, Y., Nakano, M., Kajiyama, T., Hayashi, T., Ito, R., Takahira, H., & Kobayashi, Y. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.01.006 · Cited by 26
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
AlTurki, A., Marafi, M., Russo, V., Proietti, R., & Essebag, V. (2019) · Medicina · doi:10.3390/medicina55100611 · Cited by 27
“After adjustment for stroke predictors, SCAF remained predictive of the stroke or systemic embolism [1].”
BackgroundMethodInfluentialReiffel, J. A., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Elkind, M. S. V., Ziegler, P., Kaplon, R. E., Sherfesee, L., & Wachter, R. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.07.016 · Cited by 26
Sawyer, L., Witte, K. K., Reynolds, M. R., Mittal, S., Jones, F. G., Rosemas, S. C., Ziegler, P., Kaplon, R. E., & Yaghi, S. R. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0224 · Cited by 26
McIntyre, W. F., Wang, J., Benz, A. P., Johnson, L., Connolly, S. J., Gelder, I. C. V., Lópes, R. D., Gold, M. R., Hohnloser, S. H., Lau, C., et al. (2021) · EP Europace · doi:10.1093/europace/euab324 · Cited by 26
VDD vs DDD Pacemakers: A Meta-analysis
Shurrab, M., Elitzur, Y., Healey, J. S., Gula, L. J., Kaoutskaia, A., Israel, C. W., Lau, C., & Crystal, E. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.04.035 · Cited by 26
Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland
Moran, P. S., Teljeur, C., Harrington, P., Smith, S. M., Smyth, B., Harbison, J. A., Normand, C. E. M., & Ryan, M. (2016) · Value in Health · doi:10.1016/j.jval.2016.07.007 · Cited by 26
Stavrakis, S., Stoner, J. A., Kardokus, J., Garabelli, P. J., Po, S. S., & Lazzara, R. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0192-8 · Cited by 26
Eerikäinen, L. M., Bonomi, A. G., Dekker, L. R. C., Vullings, R., & Aarts, R. M. (2020) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2020.03.001 · Cited by 24
Future of Implantable Devices for Cardiac Rhythm Management
Lau, C., Siu, C., & Tse, H. (2014) · Circulation · doi:10.1161/circulationaha.112.000312 · Cited by 25
Yano, Y., Greenland, P., Lloyd‐Jones, D. M., Daoud, E. G., Koehler, J. L., & Ziegler, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148914 · Cited by 25
North American Thrombosis Forum, AF Action Initiative Consensus Document
Ruff, C. T., Ansell, J., Becker, R. C., Benjamin, E. J., Deicicchi, D. J., Estes, N. A. M., Ezekowitz, M. D., Fanikos, J. R., Fareed, J., Garcia, D. A., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.001 · Cited by 24
Vallurupalli, S., Shanbhag, A., & Mehta, J. L. (2017) · Clinical Cardiology · doi:10.1002/clc.22652 · Cited by 25
Smartphone-based Arrhythmia Detection: Should we encourage patients to use the ECG in their pocket?
White, R. D., & Flaker, G. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1605 · Cited by 25
Ntaios, G., Perlepe, K., Lambrou, D., Sirimarco, G., Strambo, D., Eskandari, A., Karagkiozi, E., Vemmou, A., Korompoki, E., Manios, E. D., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.104626 · Cited by 25
Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC‐PET Study
Johansen, M. C., Mosley, T. H., Knopman, D. S., Wong, D. F., Ndumele, C. E., Shah, A. M., Solomon, S. D., & Gottesman, R. F. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018399 · Cited by 24
“Body mass index, mean (SD), kg/m2 29 (5)”
Ungar, A., Pescini, F., Rafanelli, M., Angelis, M. V. D., Faustino, M., Tomaselli, C., Petrone, A., Forleo, G. B., Morani, G., Forlivesi, S., et al. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.06.022 · Cited by 25
Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.025 · Cited by 28
Trohman, R. G., Huang, H. D., & Sharma, P. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1060030 · Cited by 29
Melduni, R. M., & Cullen, M. W. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.654 · Cited by 23
Silent Atrial Fibrillation in Elderly Pacemaker Users: A Randomized Trial Using Home Monitoring
Lima, C., Martinelli, M., Peixoto, G., de Siqueira, S. F., Wajngarten, M., Silva, R. T., Costa, R., Filho, R. K., & Ramires, J. A. F. (2015) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12294 · Cited by 25
Bisson, A., Bodin, A., Clémenty, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.11.016 · Cited by 24
Thind, M., Holmes, D. N., Badri, M., Pieper, K. S., Singh, A., Blanco, R. G., Steinberg, B. A., Fonarow, G. C., Gersh, B. J., Mahaffey, K. W., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.07.045 · Cited by 25
Miyazawa, K., Pastori, D., Li, Y., Székely, O., Shahid, F., Boriani, G., & Lip, G. Y. H. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01432-y · Cited by 25
Biffi, M., Iori, M., Maria, E. D., Bolognesi, M. G., Placci, A., Calvi, V. I., Allocca, G., Ammendola, E., Carinci, V., Boggian, G., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14396 · Cited by 25
“Implanted pacemakers and defibrillators (implanted cardioverter‐ defibrillator, ICDs) with an atrial lead revealed a high incidence of atrial high‐rate episodes (AHRE) associated with an increased risk of overt AT/AF and thromboembolic events.(5,6) Despite the Guidelines of the European Society of Cardiology (ESC) for…”
BackgroundResultHeart-Rhythm Monitoring for Evaluation of Cryptogenic Stroke
Kamel, H. (2014) · New England Journal of Medicine · doi:10.1056/nejme1405046 · Cited by 25
Meyer, C., Kahle, A., Dagres, N., Derval, N., Dewland, T. A., Drago, F., Eckardt, L., Frontera, A., Gerstenfeld, E. P., Hardy, C. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf324 · Cited by 25
Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
Abraham, J. M., & Connolly, S. J. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9420-4 · Cited by 24
Ictus en adultos jóvenes: incidencia, factores de riesgo, tratamiento y pronóstico
González-Gómez, F. J., Pérez‐Torre, P., DeFelipe, A., Vera, R., Matute, C., Cruz-Culebras, A., Álvarez‐Velasco, R., & Masjuán, J. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.05.008 · Cited by 24
Anticoagulation in Atrial Fibrillation – Current Concepts
Katritsis, D. G., Gersh, B. J., & Camm, A. J. (2015) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2015.04.02.100 · Cited by 26
Castro‐Urda, V. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2078 · Cited by 24
Síndrome de Bayés. Lo que todo clínico debe conocer
Bayés‐Genís, A., Martínez‐Sellés, M., Bayés‐Genís, A., Elosúa, R., & Baranchuk, A. M. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.04.003 · Cited by 25
Chang, S., Kuo, M., Lin, Y., Chen, S., Chen, C.-T., Yang, Y., Yang, L.-Y., Kao, S., Shulruf, B., & Lee, F. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000555 · Cited by 24
“Take a bath and keep the wound clean and dry within 7 d after ablation procedure; [3].”
BackgroundMethodInfluentialBlé, M., Benito, B., Cuadrado‐Godia, E., Pérez-Fernández, S., Gómez, M., Mas‐Stachurska, A., Tizón‐Marcos, H., Balaguer, L. M., Martí‐Almor, J., & Cladellas, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163501 · Cited by 24
“AF in CrS can appear as a paroxysmal and asymptomatic form, which leads to underdiagnosed cases [11,12].”
BackgroundHelms, T. M., Duong, G., Zippel‐Schultz, B., Tilz, R. R., Kück, K., & Karle, C. A. (2014) · The EPMA Journal · doi:10.1186/1878-5085-5-15 · Cited by 23
Baturova, M. A., Lindgren, A. G., Carlson, J., Shubik, Y. V., Olsson, S. B., & Platonov, P. G. (2014) · EP Europace · doi:10.1093/europace/euu165 · Cited by 24
Silent Atrial Fibrillation and Cryptogenic Strokes
Dalen, J. E., & Alpert, J. S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.027 · Cited by 24
Tarniceriu, A., Harju, J., Yousefi, Z. R., Vehkaoja, A. T., Parák, J., Yli‐Hankala, A., & Korhonen, I. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8513197 · Cited by 24
“Even if AF may display symptoms such as heart palpitations, shortness of breath, or lightheadedness [2], it is asymptomatic in at least one third of the cases [3].”
BackgroundMuntané‐Carol, G., Ureña, M., y, L. N.-F., Amat-Santos, I. J., Kleiman, N. S., Muñoz-García, A. J., Atienza, F., Serra, V., Deyell, M. W., Fernández, G. V., et al. (2020) · EP Europace · doi:10.1093/europace/euaa213 · Cited by 24
Kim, M. H., Kim, T., Yu, H. T., Choi, E., Park, H.-S., Park, J., Lee, Y. S., Kang, K., Uhm, J., Sung, J., et al. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2020.0393 · Cited by 23
Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia
Belkin, M. N., Soria, C. E., Waldo, A. L., Borleffs, C. J. W., Hayes, D. L., Tung, R. H., Singh, J. P., & Upadhyay, G. A. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005393 · Cited by 23
Oguz, M., Lanitis, T., Li, X., Wygant, G. D., Singer, D. E., Friend, K. E., Hlavacek, P. R., Nikolaou, A., & Mattke, S. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00542-y · Cited by 23
Cardiac monitoring for patients with palpitations
Pascual, J. F., Romero, J. C., Pérez‐Rodon, J., Benito, B., Santos‐Ortega, A., Maldonado, J., González, I. F., & Rivas‐Gándara, N. (2021) · World Journal of Cardiology · doi:10.4330/wjc.v13.i11.608 · Cited by 23
Marazzato, J., Blasi, F., Golino, M., Verdecchia, P., Angeli, F., & Ponti, R. D. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9040110 · Cited by 23
Automated Atrial Fibrillation Detection with ECG
Wei, T.-R., Lu, S., & Yan, Y. (2022) · Bioengineering · doi:10.3390/bioengineering9100523 · Cited by 24
“Over 10% of patients with hypertension but no A-fib history were detected as having atrial tachyarrhythmias, which were associated with an increased risk of clinical atrial fibrillation [12].”
BackgroundPathophysiology and clinical relevance of atrial myopathy
Tubeeckx, M., Keulenaer, G. W. D., Heidbüchel, H., & Segers, V. F. M. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01038-0 · Cited by 25
“Some studies suggest that atrial remodeling, rather than rhythm, is a significant stroke risk factor [246, 263] and therefore should guide initiation of anticoagulant therapy [97, 181].”
Left Atrial Appendage Exclusion for Atrial Fibrillation
Syed, F. F., DeSimone, C. V., Friedman, P. A., & Asirvatham, S. J. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.07.006 · Cited by 23
Ischemic Stroke Phenotype in Patients With Nonsustained Atrial Fibrillation
Arsava, E. M., Baş, D. F., Atalar, E., Has, A. C., Oğuz, K. K., & Topçuoğlu, M. A. (2015) · Stroke · doi:10.1161/strokeaha.114.006396 · Cited by 23
Barra, S., & Fynn, S. P. (2014) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2014.08.002 · Cited by 23
Lau, C., Siu, C.-W., Yiu, K., Lee, K. L., Chan, Y., & Tse, H. (2015) · EP Europace · doi:10.1093/europace/euv235 · Cited by 23
Performance of Atrial Fibrillation Detection in a New Single‐Chamber ICD
Deshmukh, A. J., BROWN, M. L., HIGGINS, E., SCHOUSEK, B., Abeyratne, A., Rovaris, G., & Friedman, P. A. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12918 · Cited by 23
Campal, J. M. R., Benezet‐Mazuecos, J., Bravo, J. A. I., Borque, P. S., Blanco, Á. M., Alarcón, J. J. D. L. V., Mariscal, J. M., Baranchuk, A. M., & Farré, J. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13268 · Cited by 23
Esposito, G., Piras, P., Evangelista, A., Nuzzi, V., Nardinocchi, P., Pannarale, G., Torromeo, C., & Puddu, P. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-43855-7 · Cited by 22
Xu, Y., Chang, A. R., Inker, L. A., McAdams‐DeMarco, M., Grams, M. E., & Shin, J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025723 · Cited by 22
Fabritz, L., Connolly, D. L., Czarnecki, E., Dudek, D., Guasch, E., Haase, D., Huebner, T. A., Złahoda-Huzior, A., Jolly, K. B., Kirchhof, P. F., et al. (2022) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztac067 · Cited by 23
“Rare arrhythmias of 6 min duration or more, detected within three months of screening using an implanted device, are associated with an increased risk of stroke.(10,22) Six minutes of atrial arrhythmias are also sufficiently long to allow good differentiation of atrial arrhythmias from artefacts or other rhythm irregu…”
BackgroundFumagalli, C., Bonanni, F., Beltrami, M., Ruggieri, R., Zocchi, C., Tassetti, L., Maurizi, N., Berteotti, M., Zampieri, M., Argirò, A., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.04.008 · Cited by 22
Kim, Y.-H., Lee, M., Yoon, J., Kim, Y., Min, H., Cho, H., Park, J., & Shin, T. (2023) · Diagnostics · doi:10.3390/diagnostics13172849 · Cited by 22
Gruwez, H., Verbrugge, F. H., Proesmans, T., Evens, S., Vanacker, P., Rutgers, M. P., Vanhooren, G., Bertrand, P. B., Pison, L., Haemers, P., et al. (2023) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztad054 · Cited by 23
Noujaim, C., Assaf, A. Y. M., Lim, C., Feng, H., Younes, H., Mekhael, M., Chouman, N., Shamaileh, G., Hajjar, A. H. E., Ayoub, T. H., et al. (2024) · EP Europace · doi:10.1093/europace/euae104 · Cited by 24
Iori, M., Giacopelli, D., Quartieri, F., Bottoni, N., & Manari, A. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12421 · Cited by 22
Fauchier, L., Alonso, C., Anselme, F., Blangy, H., Bordachar, P., Bovéda, S., Clémenty, N., Defaye, P., Deharo, J., Friocourt, P., et al. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.04.004 · Cited by 22
Refinement of detecting atrial fibrillation in stroke patients: results from the TRACK ‐ AF Study
Reinke, F., Bettin, M., Ross, L., Kochhäuser, S., Kleffner, I., Ritter, M., Minnerup, J., Dechering, D. G., Eckardt, L., & Dittrich, R. (2017) · European Journal of Neurology · doi:10.1111/ene.13538 · Cited by 22
“pAF increases stroke risk and is one of the main causes for “cryptogenic” stroke [5,6].”
Sanna, T., Ziegler, P., & Crea, F. (2018) · Clinical Cardiology · doi:10.1002/clc.22876 · Cited by 23
Remote monitoring: Doomed to let down or an attractive promise?
Lucà, F., Cipolletta, L., Fusco, S. A. D., Iorio, A., Pozzi, A., Rao, C. M., Ingianni, N., Benvenuto, M., Madeo, A., Fiscella, D., et al. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100380 · Cited by 22
“Fabiana Lucà a,⁎, Laura Cipolletta b, Stefania Angela Di Fusco c, Annamaria Iorio d, Andrea Pozzi d, Carmelo Massimiliano Rao a, Nadia Ingianni e, Manuela Benvenuto f, Andrea Madeo g, Damiana Fiscella h, Daniela Benedetto i, Giuseppina Maura Francese h, Sandro Gelsomino j, Massimo Zecchin k, Domenico Gabrielli l, Mich…”
BackgroundLong-term Success and Follow-up After Atrial Fibrillation Ablation
Kircher, S., Hindricks, G., & Sommer, P. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760758 · Cited by 21
Comparison of 2 ambulatory patch ECG monitors: The benefit of the P-wave and signal clarity
Rho, R. W., Vossler, M. R., Blancher, S., & Poole, J. E. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.022 · Cited by 21
Bimodal classification algorithm for atrial fibrillation detection from m-health ECG recordings
Kruger, G. H., Latchamsetty, R., Langhals, N. B., Yokokawa, M., Chugh, A., Morady, F., Oral, H., & Berenfeld, O. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.11.016 · Cited by 21
Association between socioeconomic status and incident atrial fibrillation
Ramkumar, S., Ochi, A., Yang, H., Nerlekar, N., D’Elia, N. W., Potter, E. L., Murray, I. C., Nattraj, N., Wang, Y., & Marwick, T. H. (2018) · Internal Medicine Journal · doi:10.1111/imj.14214 · Cited by 21
Kim, M. H., Kang, Y., You, S. C., Park, H., Lee, S., Kim, T., Yu, H. T., Choi, E., Park, H., Park, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-03914-4 · Cited by 22
“The study population included patients (1) eligible for permanent pacemaker implantation according to the guidelines on cardiac pacemaker implantation for sick sinus syndrome (sinus bradycardia, sinus pause of ≥ 3 s, tachy-brady syndrome, sinus node dysfunction, and chronotropic incompetence) or atrioventricular block…”
MethodKreimer, F., Mügge, A., & Gotzmann, M. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02000-7 · Cited by 23
Madsen, C. L., Park-Hansen, J., Irmukhamedov, A., Carranza, C. L., Rafiq, S., Rodríguez-Lecoq, R., Palmer, N. E., Modrau, I. S., Hansson, E. C., Jeppsson, A., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.06.003 · Cited by 21
Atrial Fibrillation and Dementia: Pathophysiological Mechanisms and Clinical Implications
Varrias, D., Saralidze, T., Borkowski, P., Pargaonkar, S., Spanos, M., Bazoukis, G., & Kokkinidis, D. G. (2024) · Biomolecules · doi:10.3390/biom14040455 · Cited by 23
“As highlighted by Healy et al., frequently silent infarcts are miss-characterized as “innocent, underestimating their clinical significance and the risk of developing into fatal strokes [34].”
BackgroundNewton‐Cheh, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.786 · Cited by 21
Detecting the Elusive P-Wave: A New ECG Lead to Improve the Recording of Atrial Activity
Kennedy, A., Finlay, D., Guldenring, D., Bond, R., & McLaughlin, J. A. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2450212 · Cited by 21
Kim, B. S., Chun, K. J., Hwang, J. K., Park, S., Park, K., Kim, J. S., & On, Y. K. (2016) · Medicine · doi:10.1097/md.0000000000004181 · Cited by 21
Relevance of supraventricular runs detected after cerebral ischemia
Weber-Krüger, M., Lutz, C., Zapf, A., Stahrenberg, R., Seegers, J., Witzenhausen, J., Wasser, K., Hasenfuss, G. P., Gröschel, K., & Wachter, R. (2017) · Neurology · doi:10.1212/wnl.0000000000004487 · Cited by 21
Fay, M., Fitzmaurice, D. A., & Freedman, B. (2017) · European Journal of General Practice · doi:10.1080/13814788.2017.1374366 · Cited by 21
“A major diagnostic challenge relates to those with paroxysmal or asymptomatic (silent) AF, particularly given the results of the ASSERT and Copenhagen Holter studies, which clearly indicate that even short episodes of ‘silent’ AF are associated with an increased risk of stroke [15,16].”
ResultClinical significance of atrial high-rate episodes for thromboembolic events in Japanese population
Kawakami, H., Nagai, T., Saito, M., Inaba, S., Seike, F., Nishimura, K., Inoue, K., Okura, T., Sumimoto, T., Uemura, S., et al. (2017) · Heart Asia · doi:10.1136/heartasia-2017-010954 · Cited by 22
Bettin, M., Dechering, D. G., Kochhäuser, S., Bode, N., Eckardt, L., Frommeyer, G., & Reinke, F. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1358-4 · Cited by 21
Stroke Prevention in Atrial Fibrillation
Mtwesi, V., & Amit, G. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.05.006 · Cited by 21
Afzal, M. R., Nadkarni, A., Niemet, L., Houmsse, M. M., Devgun, J. K., Koppert, T. L., Ferguson, K., Mease, J., Okabe, T., Houmsse, M., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.10.014 · Cited by 21
Mannina, C. M., Jin, Z., Matsumoto, K., Ito, K., BIVIANO, A. B., Elkind, M. S. V., Rundek, T., Homma, S., Sacco, R. L., & Tullio, M. R. D. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.05.006 · Cited by 21
Metadata
- Authors
- Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., Morillo, C. A., Carlson, M., Themeles, E., Kaufman, E. S., & Hohnloser, S. H.
- Affiliations
- Population Health Research Institute (CA)
- Medical University of South Carolina (US)
- Goethe University Frankfurt (DE)
- Marche Polytechnic University (IT)
- Queen Mary Hospital (CN)
- MetroHealth (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-01-12
- Volume
- 366
- Issue
- 2
- Pages
- 120-129
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154658516
- Cited by
- 2,100
- References
- 37
- Citations by year
- 2026: 87 · 2025: 104 · 2024: 137 · 2023: 116 · 2022: 134 · 2021: 153 · 2020: 148 · 2019: 162 · 2018: 154 · 2017: 154 · 2016: 162 · 2015: 146 · 2014: 181 · 2013: 133 · 2012: 124
- FWCI
- 120.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- subclinical atrial fibrillation, atrial tachyarrhythmia, ischemic stroke, systemic embolism, atrial overdrive pacing, atrial fibrillation risk, hypertension, elderly patients, population attributable risk, stroke prevention, cardiac implantable electronic devices, atrial fibrillation detection, atrial fibrillation prevention
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Cardiac Pacing, Artificial, Embolism, Female, Humans, Hypertension, Male, Pacemaker, Artificial, Prospective Studies, Risk, Defibrillators, Implantable, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review